Removing Obstacles to cervical ScrEening

In Malaysia, cervical cancer is the top 3 most common cancer among women.

Cervical cancer strikes women in the prime of their lives - 3 out of 4 women in Malaysia with cervical cancer are below the age of 64.

99% of cervical cancer cases are caused by high-risk HPV (Human Papillomavirus) types.

Only 25% of eligible women had a pap smear done from 2013 to 2017.

Barriers to a successful screening program related to the conventional screening method, Pap smear are:

• Fear
• Embarrassment
• Inconvenience
• Lack of awareness about cervical screening
• Poor infrastructure
• Lack of dedicated resources/staff

Program ROSE uses a revolutionary approach to cervical screening by:

1. Featuring self-sampling by women themselves, instead of pelvic examination by healthcare professionals.
2. HPV testing, instead of a pap smear diagnostic test for abnormal cells.
3. Using a secure digital e-health platform that empowers women to register and have all their follow up communicated through their mobile phone.

Pilot Project ROSE is a research program led by University of Malaya that aims to assess acceptability, feasibility and reach of a novel cervical screening strategy that utilizes self-collected,HPV testing in primary care settings and follow-up of screened positive women in tertiary hospital in Malaysia.

The overall program encompasses a series of pilot projects that is designed to screen more women and systematically evaluate the outcomes in the different community settings (e.g. urban poor and rural) within the Malaysian setting.  The results generated will inform the stakeholders on strategies to increase uptake of cervical screening in the most cost effective, acceptable and feasible manner in the Malaysian context.

This fundraising drive will enable a pilot project that will screen 2000 women to be executed using the ROSE intervention.

'Our vision is a cervical cancer free future for Malaysian women'

Please join us in making cervical cancer history!